As of 2025-07-09, the Relative Valuation of Erytech Pharma SA (ERYP.PA) is 0.12 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 EUR, the upside of Erytech Pharma SA based on Relative Valuation is -75.0%.
The range of the Relative Valuation is (0.08) - 0.50 EUR.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 10.0x | 9.4x |
| Forward P/E multiples | 14.0x - 43.3x | 28.6x |
| Fair Price | (0.08) - 0.50 | 0.12 |
| Upside | -115.2% - 0.1% | -75.0% |
| Date | P/E |